1st Quarter - Report
WILLIAMS AND JENSEN, PLLC for PFIZER
Client
Income
$80,000
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Tax issues affecting the pharmaceutical industry including international tax. Revenue proposals on international tax. Issues related to tax reform.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DENIS DWYER | — |
| CHRISTOPHER W HATCHER | — |
| SUSAN HIRSCHMANN | — |
| MATTHEW B HOEKSTRA | — |
| KARINA LYNCH | — |
| GEORGE OLSEN New | — |
Health Issues HCR
Drug safety and drug counterfeiting; Rebates for Medicare Part D; animal health; Federal preemption for prescription drugs; drug importation; and drug shortages. H.R. 1513; S. 810
| Lobbyist | Covered position, as disclosed |
|---|---|
| REBECCA ANDERSON | — |
| JENNY DIJAMES | — |
| DENIS DWYER | — |
| JACK STEVEN HART | — |
| CHRISTOPHER W HATCHER | — |
| SUSAN HIRSCHMANN | — |
| MATTHEW B HOEKSTRA | — |
| KARINA LYNCH | — |
| MELINDA M MAXFIELD | — |
| ERIN BOOK MULLEN | — |
| GEORGE OLSEN | — |
| JOEL OSWALD | — |
| PATRICK PETTEY | — |
| ANTHONY J RODA | — |
Medicare/Medicaid MMM
Medicare payment issues including the Independent Payment Advisory Board (IPAB) and Medicaid issues. Medicare Part D.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SUSAN HIRSCHMANN | — |
| MATTHEW B HOEKSTRA | — |
| KARINA LYNCH | — |
| ERIN BOOK MULLEN | — |
| GEORGE OLSEN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.